Interestingly, contrary to previous studies linking IGF2BP1 overexpression to tumor aggressiveness22, 23, our findings revealed that patients with high IGF2BP1 expression—and concomitantly elevated caspase-3—exhibited better overall survival. The gene discussed is CASP3; the disease is neoplasm.